A patient with refractory high-grade B-cell lymphoma and rapid progression under CAR-T-cell therapy was successfully salvaged with inotuzumab- ozogamicin. Issue 9 (29th July 2022) - Strüßmann, T.; Wäsch, R.; Scherer, F.; Mutter, J. A.; Pfeifer, D.; Bartsch, I.; Giesler, S.; Graziani, G.; Duyster, J.; Finke, J.; Marks, R.